Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, and Merck & Co., Inc.

Community Practice Connections™: The Latest Advances on PARP Inhibition in Ovarian Cancer: What You Need to Know

Release Date: June 30, 2020
Expiration Date: June 30, 2021

Activity Overview

This online program will review current guidelines, best practices, and new data in ovarian cancer with expert commentary from renowned leaders in the treatment of ovarian cancer. Case discussions explore common clinical challenges encountered in the community setting when treating patients with PARP inhibitors as well as personalized therapy implementation, combination strategies, and management of associated adverse events.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, and Merck & Co., Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward medical, surgical and radiation oncologists who treat or manage patients with ovarian cancer. Pathologists, fellows, nurses, nurse practitioners, physician assistants, researchers, pharmacists and other health care professionals interested in the treatment or management of these tumors are also invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Assess timing and selection of molecular testing methods for patients with ovarian cancer based on current evidence and treatment guidelines
  • Review key findings from clinical trials that have evaluated PARP inhibitors for patients with ovarian cancer in the treatment and maintenance settings
  • Examine strategies that are being explored to personalize PARP inhibitor use for patients with ovarian cancer including combination strategies
  • Utilize effective measures to manage and mitigate adverse events associated with PARP inhibitor use

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Susana Campos, MD, MPH
Susana Campos, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber MA Cancer Institute
Boston, MA

Disclosures: Consultant: Tesaro, Eisai.

Ursula A. Matulonis, MD
Ursula A. Matulonis, MD
Chief, Division of Gynecologic Oncology
Brock-Wilson Family Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures: Consultant: Merck, Novartis. Other Travel: Astrazeneca.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By